Incident Cerebral Microbleeds Detected by Susceptibility Weight-Imaging Help to Identify Patients with Mild Cognitive

Hubert Basselerie1, Luc Bracoud2, Eva Zeestraten2

  • 1Service de Neuro-Radiologie, Centre Hospitalier Universitaire Toulouse - Purpan, Hôpital Pierre Paul Riquet, Toulouse, France.

Abstract

Insights

Susceptibility-weighted imaging (SWI) detected new cerebral microbleeds (CMB) in patients with Alzheimer's disease (AD) and progressing mild cognitive impairment (MCI-p). Incident CMB may serve as an imaging biomarker for AD progression.

Area of Science:

  • Neurology
  • Radiology
  • Neuroimaging

Background:

  • The link between cerebral microbleeds (CMB) and Alzheimer's disease (AD) remains unclear, especially when using susceptibility-weighted imaging (SWI).
  • SWI is a specialized MRI technique sensitive to blood products.

Purpose of the Study:

  • To assess the utility of 3T MRI SWI for detecting CMB.
  • To determine if SWI can differentiate between elderly controls (CS), stable mild cognitive impairment (MCI-s), progressing MCI (MCI-p), and AD patients.

Main Methods:

  • A prospective, observational study in Toulouse, France, included 150 participants (48 CS, 25 MCI-s, 18 MCI-p, 59 AD) aged 65+.
  • Participants underwent MRI scans at baseline (MRI#1) and after 4 years (MRI#3).
  • Cerebral microbleeds were quantified using native SWI and minIP reformatted images.

Main Results:

  • No significant difference in CMB prevalence was found between groups at baseline or follow-up.
  • However, the MCI-p + AD group showed significantly more incident CMB (≥4) compared to the CS + MCI-s group (p=0.016).
  • The MCI-p + AD group also had a significantly higher prevalence of >4 CMB at MRI#3 versus MRI#1 (p=0.008).

Conclusions:

  • Alzheimer's disease and MCI-p patients developed more new CMB over 4 years compared to controls and MCI-s patients.
  • Incident CMB detected by SWI may indicate Alzheimer's disease progression.